Nanogen Pharmaceutical Biotechnology Joint Stock Company

This trial compares a new erythropoietin drug called Nanokine to the approved drug Eprex in healthy male volunteers. The goal is to see if Nanokine is absorbed and processed by the body similarly to Eprex, and whether it has a comparable effect on red blood cell production. Each …